Floatz logo

MAGNESIUM METALLICUM

Pre-eclampsia

Oregon Health and Science UniversitySmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Pre-eclampsia cohort.

Asset / SponsorPhaseRating
Nimodipine
FDA Office of Orphan Products Development
N/AD

Same molecule, other indications

MAGNESIUM METALLICUM is also rated in:

sickle cell diseaseDormant
BB
Indicative ·
70 / 100
View asset →
Alcohol WithdrawalDormant
BB
Indicative ·
70 / 100
View asset →
Brain InjuriesDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →